DrugPatentWatch Database Preview
Ethinyl estradiol; segesterone acetate - Generic Drug Details
What are the generic drug sources for ethinyl estradiol; segesterone acetate and what is the scope of freedom to operate?
Ethinyl estradiol; segesterone acetate
is the generic ingredient in one branded drug marketed by Therapeuticsmd Inc and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are twenty-six drug master file entries for ethinyl estradiol; segesterone acetate. One supplier is listed for this compound.
Summary for ethinyl estradiol; segesterone acetate
| US Patents: | 6 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 26 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 2 |
| DailyMed Link: | ethinyl estradiol; segesterone acetate at DailyMed |
Recent Clinical Trials for ethinyl estradiol; segesterone acetate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| TherapeuticsMD | Phase 1 |
See all ethinyl estradiol; segesterone acetate clinical trials
Pharmacology for ethinyl estradiol; segesterone acetate
| Drug Class | Progestin Estrogen |
| Mechanism of Action | Estrogen Receptor Agonists |
ATC Classes for ethinyl estradiol; segesterone acetate
US Patents and Regulatory Information for ethinyl estradiol; segesterone acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ||||
| Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | Y | ⤷ Free Forever Trial | |||
| Therapeuticsmd Inc | ANNOVERA | ethinyl estradiol; segesterone acetate | RING;VAGINAL | 209627-001 | Aug 10, 2018 | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
